Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: A double-blind randomized trial of 100 patients with 1-year follow-up
Acta Orthopaedica, 04/24/07
Josef G. Grohs, et al. - Recent reports have suggested that selective COX-2 inhibition may be sufficient for the prevention of heterotopic ossification...After short-term administration, the selective COX-2 inhibitor rofecoxib was effective in preventing heterotopic ossification after total hip arthroplasty
Related Articles
Heterotopic Ossification Following Traumatic Brain Injury and Spinal Cord Injury
Journal of the American Academy of Orthopedic Surgeons, 11/13/09
Relevance Score: 68%
Risk of symptomatic heterotopic ossification following plate osteosynthesis in multiple trauma patients: an analysis in a level-1 trauma centre
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 10/14/09
Relevance Score: 66%
Impact of late surgical intervention on heterotopic ossification of the hip after traumatic neurological injury
The Journal of Bone and Joint Surgery (British Volume), 11/03/09
Relevance Score: 64%
Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials
International Orthopaedics, 10/19/09
Relevance Score: 64%
Value of 3D CT in Defining Skeletal Complications of Orthopedic Hardware in the Postoperative Patient
American Journal of Roentgenology, 10/08/09
Relevance Score: 64%
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Magnesium sulphate in the treatment of acute asthma: evaluation of current practice in adult emergency departments
Emergency Medicine Journal, 12/02/09
FDA Approval for Uveitis Treatment for Sirion's Durezol
Review of Ophthalmology, 12/02/09
Clinical Studies of Liraglutide, a Novel, Once-Daily Human Glucagon-Like Peptide-1 Analog for Improved Management of Type 2 Diabetes Mellitus
Pharmacotherapy, 12/02/09
Sponsor
Article Search
Sponsor


See Latest Articles


